South Korean Lawmaker: Inclusion of Synthetic Nicotine in Taxation and Regulation

Regulations by 2FIRSTS.ai
Jan.09.2024
South Korean Lawmaker: Inclusion of Synthetic Nicotine in Taxation and Regulation
South Korean lawmaker, Choi Hye-young, suggests imposing taxes and regulations on e-cigarette e-liquids containing synthetic nicotine for public health concerns.

According to a report by South Korean news portal Naver on August 8th, data obtained by Korean lawmaker Choi Hye-young from customs revealed that a total of 378 tons of e-liquid was imported in 2021, with 98 tons of it containing synthetic nicotine, accounting for 26% of the total.

 

Currently, natural nicotine is subject to consumption tax, value-added tax, and a national health promotion fee, as well as local tobacco consumption tax and local education tax. However, synthetic nicotine is not subject to any taxes or fees. According to the Congressional Budget Policy Office, starting next year, synthetic nicotine will be subject to the same taxation and health promotion fees as natural nicotine. It is estimated that this measure will increase tax revenue by 101.2 billion Korean won over the next five years.

 

The e-cigarette industry produces e-liquid by diluting synthesized nicotine, with taxes and fees being levied on the final e-liquid product. As a result, the expected benefits of actual tax revenue are anticipated to be higher than projected. Kim Dohwan, Vice President of the Korean E-Cigarette Association, stated that "natural nicotine is typically in a finished state, whereas 1 ton of synthesized nicotine can produce approximately 90 tons of e-liquid products.

 

Under current regulations, e-liquid advertisements are not subject to the same strict restrictions as regular tobacco and online sales cannot be stopped. As 59% of synthetic nicotine comes from China, "Chinese companies are taking advantage of the regulatory gray area to profit," according to industry insiders.

 

Currently, the amendment to the Tobacco Business Act, which classifies e-cigarettes as "tobacco" and includes them in the scope of regulation, is being reviewed in the Congressional Finance and Planning Committee. However, due to the Ministry of Finance's insistence that the toxicity and safety of synthetic nicotine have not been confirmed, and their opposition to including it in the scope of tobacco, the amendment has not made substantial progress. Regarding e-liquid, some have pointed out the need for measures to be introduced from a public health perspective due to a lack of awareness.

 

According to a recent paper published by a research team from the Qiming Medical University, the analysis of adult e-cigarette usage and smoking cessation plans in South Korea reveals that users of e-liquids have no intention of quitting smoking, with a likelihood of continued tobacco use that is 1.8 times higher than that of traditional tobacco users. Assemblywoman Choi Hye-young emphasized that "even if it is only for the sake of public health, synthetic nicotine should be included in taxation and regulatory frameworks.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

WHO’s First Global Report on Nicotine Pouches: Harm Reduction Questions Remain Amid Global Regulatory Warning
WHO’s First Global Report on Nicotine Pouches: Harm Reduction Questions Remain Amid Global Regulatory Warning
Ahead of World No Tobacco Day 2026, WHO released its first global report on nicotine pouches, warning that rapid market growth, youth-oriented marketing and weak regulation are converging. 2Firsts views the report as an important warning, but not a complete risk assessment, with harm-reduction questions still unresolved.
Special Report
May.17
The new regulations on nicotine in Argentina are creating caution, expectations, and doubts about the market, according to a local reference in harm reduction for smoking.
The new regulations on nicotine in Argentina are creating caution, expectations, and doubts about the market, according to a local reference in harm reduction for smoking.
The new Argentine framework for tobacco and nicotine marks a shift from prohibition towards registration, traceability, and health surveillance. Juan Facundo Teme told 2Firsts that adult consumers and some of the commercial sector are cautiously optimistic, although concerns remain about flavors, registration costs, and market access.
May.11
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Summary Ispire Technology announced a strategic joint venture with Chinese pharmaceutical company Jincheng Pharma to manufacture and commercialize nicotine pouch products. The partnership combines pharmaceutical-grade production capabilities with Ispire’s global regulatory infrastructure and distribution network as the company expands beyond vaping hardware into oral nicotine products.
Business
May.13
Chinese Disposable Brands OXBAR, LYCO Challenge Vuse and JUUL: Pennsylvania’s Pending List Offers a Glimpse of the Future Legal Vape Market
Chinese Disposable Brands OXBAR, LYCO Challenge Vuse and JUUL: Pennsylvania’s Pending List Offers a Glimpse of the Future Legal Vape Market
Pennsylvania’s June 26 ENDS Pending Certifications list previews the state’s future legal vape market, placing Vuse, JUUL and Logic alongside Chinese-linked disposable brands OXBAR and LYCO. Shaped by PMTA eligibility and state rules, the list shows competition shifting from market share to market access.
Special Report
Jul.06
PMI Partners With Italian Tenor Andrea Bocelli to Launch “Believe. Further” Platform
PMI Partners With Italian Tenor Andrea Bocelli to Launch “Believe. Further” Platform
Philip Morris International (PMI) and Italian tenor Andrea Bocelli have launched “Believe. Further,” a multi-year communications platform targeting cultural, institutional and business audiences in Europe, as PMI says smoke-free products accounted for 43% of its net revenues as of the first quarter of 2026.
Jul.01
U.S. Senator Durbin Criticizes FDA’s First Flavored Vape Authorization, Says Trump Administration Conceded to Big Tobacco
U.S. Senator Durbin Criticizes FDA’s First Flavored Vape Authorization, Says Trump Administration Conceded to Big Tobacco
U.S. Senator Dick Durbin on May 13 criticized the Trump Administration’s Food and Drug Administration for approving the sale and marketing of fruit-flavored e-cigarettes for the first time, while also allowing some illegal vaping products to remain on the market. He also linked the regulatory shift to the departure of FDA Commissioner Marty Makary, saying White House pressure on regulators to approve tobacco product applications could create serious public-health consequences.
Regulations
May.15